STRIGoSUS
transformative medicines for weight loss
We are developing game-changing small molecules to treat excess weight and weight-related medical problems. Using the latest in drug design technology, our molecules will also have beneficial effects on blood pressure, cholesterol, and blood sugar while reducing risk of major cardiovascular events.
oral glp-1 agonists
STRIGOSUS is applying deep drug development and technical expertise to harvest the full potential of discrete receptor modulation. Here is just one druggable site on GLP-1R that we have leveraged to deliver breakthrough oral drugs to treat a broad range of patients.
Other novel metabolic targets
STRIGOSUS leverages proprietary technology (STRIGOTECH) that uses cutting edge tools like AI and computational methods along with decades of translational medicinal chemistry expertise to target proteins that were previously thought undruggable. This approach has yielded candidates with unexpected potency for various metabolic conditions.